Ikigo cya BIOOCUS CGT
Umujyi w’Ubuvuzi w’igihe kirekire wa Tianjin
Uburyo bwo kuvura uturemangingo, imiterere y'uturemangingo, n'uturemangingo (CGT) ku barwayi bo ku isi
Nk'igice cya Urugaga rw'Ubuvuzi Mpuzamahanga rwa BIOOCUS, Umujyi w’Ubuvuzi w’Imyaka Ihoraho wa Tianjin uhagaze nk'uwa Ikigo cy’ingenzi mu majyaruguru y’Ubushinwa gishinzwe ubuvuzi bwa kanseri n’ubuvuzi bwo kuvugururaIki kigo gihuza uburyo bugezweho bwo kuvura selile za CAR-T, TIL, NK, n'uturemangingo fatizo, gufasha abarwayi barenga Ibihugu 50 ku isi yose.
Kuva mu 2016, ikigo cyavuwe ku Abarwayi 1.600 ba CAR-T(guhera mu Ukwakira 2025), kugera kuri:
● 80–90% by'igabanuka ry'ibanze
●40–60% by'igihe kirekire cyo kugabanya burundu indwara (CR)
● Igipimo rusange cy'ubutabazi ku kigero cya 95% (ORR)ku ndwara za kanseri y'amaraso
● Igipimo cyo kurwanya indwara kiri hagati ya 60–92% (DCR)ku ndwara zikomeye
Ibi bisubizo bishyigikiwe na Ikoranabuhanga rya CAR-T ryazamuwe na IL-15, ibyo bikaba bitera imbere kwinjira kwa kanseri, kubaho kwa selile T, no kudakora neza kwa antigen.
Gutangira kuvura CGT bifite ibisubizo by'ubuvuzi byagaragaye
Porogaramu yuzuye y'ubuvuzi
Ubuvuzi bwa CAR-T
lIntego: CD19 / BCMA (hematologic), CLDN18.2 (igifu), GPC3 (umwijima / HCC), CEA (ibihaha / NSCLC), B7H3 (glioma), GD2 (neuroblastoma)
lIbisubizo: Kugeza kuri 90% bya CR kuri kanseri y'amaraso no kugenzura indwara mu bwoko bwa kanseri ikomeye.
Ubuvuzi bwa TIL
lIbisubizo: 40% ORR na 80% ku barwayi ba melanoma bagabanukaho ikibyimba.
Uburyo bwo kuvura uturemangingo twa NK n'uturemangingo tw'inyuma
lGushyiramo imiti ya ADC, organoids za kanseri, n'imiti ya radionuclide (Y-90, Lu-177, Ac-225) kugira ngo havurwe neza ku giti cye.
| Ubwoko bwa Kanseri | Intego | Abarwayi | ORR | DCR | Ibisubizo by'ingenzi (Amakuru ya BIOOCUS) |
| Kanseri z'amaraso | CD19 / BCMA | ~1,000 | 95%+ | – | 90% CR; 40–60% CR y'igihe kirekire |
| Kanseri zo mu nda | CLDN18.2 | 98 | 38.8% | 91.8% | mPFS 4.4m; mOS 8.8m |
| Umwijima (HCC) | GPC3 | 32 | 56.6% | 86.7% | mPFS 13m; mOS 14.6m |
| Ibihaha (NSCLC) | IKI | 10 | 55.6% | 88.9% | Porogaramu y'umwaka umwe 77.8% |
| Glioma (rHGG) | B7H3 | 39 | 30–40% | 60–70% | mOS 11–13.6m |
| Melanoma | KU | 12 | 40% | 80% | Kugabanuka kwa kanseri ku kigero cya 80% |
Umwirondoro w'umutekano:
Abarwayi benshi bahura n'ikibazo gusa CRS yoroshye; nta ICANS cyangwa impfubyagaragaye mu bushakashatsi bukomeye bw'ubuvuzi.
Ubumenyi bw'indwara zo mu bwoko bwa Multidisciplinary Precision Oncology – Ubuvuzi Buhuriweho bwa One-Stop
Umujyi w’Ubuvuzi w’igihe kirekire wa Tianjin
BIOOCUS Tianjin Perennial itanga imicungire yuzuye ya kanseri ishingiye ku itsindabinyuze kuri ubuvuzi bw’inzego zitandukanye (MDT)icyitegererezo, guhuza kubaga, ubuvuzi bw’ibanze, ubuvuzi bw’ubudahangarwa bw’umubiri, radiology, n’ubuvuzi bufasha.
Ishami ry'ibanze n'impuguke
Kubaga no kuvura kanseri yo mu bwoko bwa Oncology:Uburyo bwo kuvura bukoresha uburyo budakunze kugaragara (nanoknife, cryoablation, RFA, laparoscopy) buyobowe na Porofeseri Liang Han(kanseri yo mu gifu) na Dr. Li Liming(kanseri zo mu miyoboro y'inkari).
Ubumenyi bw'indwara ya kanseri:Uburyo bugezweho bwo kuvura hifashishijwe ubudahangarwa bw'umubiri buri munsi Dr. Yao Yaqun, ufite uburambe bw'imyaka irenga 40 mu kuvura kanseri y'igifu, ibihaha n'ibere
Ubuvuzi bwa kirimbuzi:Ibigezweho Ishusho ya PET-CTna uburyo bwo kuvura hakoreshejwe radionuclide.
Ubumenyi bw'imirasire:Ifite ibikoresho TOMO, Gamma Knife, VMAT, SBRT, na ARTsisitemu; BNCT na proton therapyiratangira vuba.
Kwita ku buzima bwose:Ihuriweho TCM, inkunga y'imirire, ubuvuzi bw'indwara zo mu mutwe (Dr. Wang Yulu), na kubaga mu buryo bwo kongera kubaka (Dr. Yin Zhuming).
Ibikoresho n'ibidukikije
A Urusobe rw'ubuvuzi rufite ibitanda 1,000guhuza ibitaro, ubuvuzi n'ibigo by'ubuzima—bitanga uburyo bwo gukira mu buryo burambye ahantu ho gukira hifashishijwe ibidukikije kandi hashingiye ku barwayi.
Ubuhanga mu by'abarwayi mpuzamahanga – Uburyo bwo kugera ku barwayi ku isi yose butagira imipaka
Umujyi w’Ubuvuzi w’igihe kirekire wa Tianjin
Ikigo gitanga Urubuga rwa serivisi za VIP rutanga serivisi imwe imwebyagenewe imiryango mpuzamahanga isaba ubuvuzi bw’icyiciro cya mbere mu Bushinwa.
Serivisi z'ingenzi:
Inama ku buntu ku bijyanye n'ubuhanga bwo gukora imibonano mpuzabitsina (AI) – Shyira inyandiko z'ubuvuzi kuri bioocus.com.
Ubufasha mu ndimi nyinshi – Icyongereza, Icyesipanyoli, n'ibindi; Abahuzabikorwa barahari amasaha 24/7.
Inkunga ya Visa n'ingendo – Kwimura abantu ku kibuga cy'indege, kwandika inyandiko, no guhuza ibikorwa byuzuye.
Kwishyura mu buryo busobanutse – Nta kiguzi cyihishe; hari amapaki yose arimo.
Uburyo bworoshye bwo kwinjira – Gusa Iminota 30 uvuye i Beijingbinyuze muri gari ya moshi yihuta cyane.
Gukurikirana mu gihe kirekire - Gukurikirana no gufasha mu gusubiza mu buzima busanzwe abarwaye indwara yandujwe n'indwara.
| Agace ka serivisi | Akamaro k'igihe kirekire ka BIOOCUS |
| Ingendo | Uburyo bwo kugera ku kibuga cya gari ya moshi + amacumbi meza cyane aho hantu |
| Guhuza ibikorwa | Serivisi ya VIP ikoresha indimi nyinshi amasaha 24/7 |
| Visa n'Ubwishingizi | Inkunga yuzuye y'ubuyobozi |
| Gukira | Gahunda zihariye zo gusubiza mu buzima busanzwe |
Itsinda ry'abaganga b'abahanga - Impamyabumenyi zo ku rwego rw'isi
| Impuguke | Ubuhanga | Ibintu by'ingenzi |
| Porofeseri Liang Han | Indwara ya kanseri y'igifu | Ibihembo by'Igihugu, inyandiko zirenga 550, ubufatanye na MD Anderson |
| Dr. Li Liming | Prostate n'impyiko | Umuyobozi wa Tianjin Oncology; "Umuganga Mukuru" |
| Dr. A.S. Pan Lekang | Kanseri y'ibere | MD/PhD wa Tokyo; yahuguwe muri Harvard na ASCO |
| Dr. Yao Yaqun | Ubudahangarwa bw'umubiri (Unimmuno-Oncology) | Ubushakashatsi bw'imyaka 40+ ku ndwara ya GI, kanseri y'ibihaha na kanseri y'ibere |
| +20 Abandi Bahanga | Kubaga Igifu, abaganga b'abagore, kubaga pulasitiki | Abahuguwe ku rwego mpuzamahanga, barimo n'abarangije muri MD Anderson |
Ikigo cya BIOOCUS CGT – Umujyi w’Ubuvuzi w’Imyaka Ihoraho wa Tianjin
Aho udushya duhurira n'impuhwe.
Gutanga ubuvuzi bw'ubudahangarwa bw'ikizamini gishyana ubuvuzi bw'abarwayi ku isi—kuva ku gusuzuma indwara kugeza ku gukira.
Ibidukikije, Serivisi z'abarwayi, n'ibindi byinshi
Umujyi w’ubuvuzi wa Tianjin uhoraho ntabwo ari ukuvura gusa—Ni ukugira ngo ushyireho ahantu ho kwita ku barwayi kandi habeho ubuzima bwiza, bigatuma urugendo rwawe rw'ubuvuzi rurushaho kuba rwiza kandi rudahangayika. Ikigo cyakozwe mu buryo bufatika nk'ahantu ho kuruhukira hagezweho kandi hagezweho muri Tianjin, hafite ahantu hanini kandi hafite urumuri ruhagije, havanga ikoranabuhanga rigezweho n'ahantu hatuje kugira ngo hagufashe gukira no kuruhuka. Aho giherereye hafi y'aho gari ya moshi yihuta cyane bituma abantu babasha kugera byoroshye, waba uvuye i Beijing, Shanghai, cyangwa mu mahanga, bikagabanya umunaniro w'ingendo kandi bigatuma umuntu arushaho gukira.
Serivisi zacu z'abarwayi zigenewe kurenza ibyo bari biteze, hamwe n'ubufasha mu ndimi nyinshi, gahunda z'ubuvuzi bwihariye, kandi hibandwa ku gukorera mu mucyo—Nta mafaranga yihishe, ibisobanuro bisobanutse gusa n'amahitamo. Ishimire ubufasha ku rwego rw'abashinzwe umutekano, harimo gahunda yo kubonana, guhuza ubwishingizi (ubu harimo na gahunda za leta), no gucumbikira imiryango muri hoteli ziri aho hantu zifite ibyumba bigera ku 1,000 mu masosiyete ane, kuva ku byumba by'akataraboneka kugeza ku byumba biri hagati. Ku gihe kirekire, umuryango wita ku bageze mu zabukuru utanga ibitanda 1,800 bifite ubuzima bwiza bwo kuvura no kuvura abageze mu zabukuru, harimo ibikorwa by'imibereho myiza nk'amahugurwa y'icyayi na salon z'umuco, bitanga ahantu heza ku bantu b'ingeri zose. Ibikoresho by'inyongera nk'ahantu ho kugurisha, amafunguro, na gahunda z'ubuzima bwiza birushaho kunoza ubunararibonye bwawe, bigatuma Perennial Tianjin Medical City itaba ibitaro gusa, ahubwo iba ahantu heza ho kurengera ubuzima bwiza n'imibereho myiza.
Itsinda ry'abaganga rya BIOOCUS
Ukwakira 2025